RxDoctor Payments DataLook up a doctor →

Nataly Apollonsky

Pediatric Hematology-Oncology · Philadelphia, PANPI 1730309246

Payments from drug & device makers

$1,600,666in general payments, 2019–2025

Across 915 payments — averaging $1749.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$1.2M
  • Agios Pharmaceuticals, Inc.$266K
  • Pfizer$47K
  • Sanofi$20K
  • Medexus Pharma, Inc.$9K
  • Global Blood Therapeutics, Inc.$7K
  • plus $8K from 5 others
$5,861in research payments, 2019–2025

Across 3 payments — averaging $1953.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$6K
  • Novo Nordisk Health Care AG$115

What the payments were for

  • Consulting fees$38,93769%
  • Speaking & faculty fees$2,1504%
  • Travel & lodging$13,66024%
  • Food & beverage$1,7313%
  • Education$2080%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,600,666 in reported general payments places this provider in the 90th percentile of 139 pediatric hematology-oncology providers in Pennsylvania.

See all pediatric hematology-oncology providers in Pennsylvania

Other pediatric hematology-oncology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →